首页> 外文期刊>Bulletin du Cancer: Journal de l'Association Francaise pour l'Etude du Cancer >Screening of hepatocellular carcinoma in patients with uncomplicated cirrhosis in real life: Practices survey of general practionners from three towns of Seine-Saint-Denis (north-east suburb of Paris)
【24h】

Screening of hepatocellular carcinoma in patients with uncomplicated cirrhosis in real life: Practices survey of general practionners from three towns of Seine-Saint-Denis (north-east suburb of Paris)

机译:筛查现实生活简单肝硬化患者肝细胞癌:从塞纳 - 圣丹尼斯(巴黎东北郊区)三镇一般实例的实践调查

获取原文
获取原文并翻译 | 示例
           

摘要

Cirrhosis is a frequent and severe pathology life threatening, due to the occurrence of complications including hepatocellular carcinoma. In order to assess the degree of conformity, of practices, with the French guidelines for the surveillance of patients with compensated cirrhosis and the primary prevention of complications, published in 2007, all general practitioners practicing in three towns from north-east suburb of Paris (Seine-Saint-Denis) representing a population pool of 186 286 inhabitants were asked during the first quarter of 2012 for the face-toface administration of a standardized questionnaire. Based on the 20 questions, individual practices were analyzed and a compliance score limited to hepatocellular carcinoma screening was established. Of the 106 practitioners surveyed, 40 have agreed to participate (85% of men, mostly based in Aulnay-sous-Bois or Sevran with an average exercice of 22 years). The declared practices were heterogeneous and did insuffisantly comply with the recommendations (mean score 1.9/3). The intent of surveillance was not influenced by the origin or severity of cirrhosis. Screening for HCC was based on appropriate tests (abdominal ultrasound, alpha-foetoprotein serum) but with optimal half-yearly intervals in less than half of the cases. Improved communication to general private practitioners of HAS recommendations for patients with compensated cirrhosis could optimize the prescribing of screening tests for hepatocellular carcinoma.
机译:由于在包括肝细胞癌包括并发症的情况发生,肝硬化是威胁的经常和严重的病理学危及危及的病理学。为了评估实践的一致性,在2007年出版的所有肝硬化患者的法国患者的患者进行监测以及对并发症的初步预防,所有普遍从业人员在巴黎东北郊区的三个城镇练习(在2012年第一季度询问了代表186个286名居民的人口池的Seine-Saint-Denis为标准化问卷的面对Toface管理。基于20个问题,分析了个别实践,并确定了限于肝细胞癌筛选的合规分数。在调查的106名从业者中,40名已同意参加(85%的男性,主要是基于Aulnay-Sous-Bois或Sevran,平均练习22岁)​​。宣布的做法是异质的,并且不断遵守这些建议(平均得分1.9 / 3)。监测的目的不受肝硬化的起源或严重程度的影响。对HCC的筛选基于适当的测试(腹部超声,α-佛罗特血清),但在不到一半的情况下最佳的半年间隔。改善与普通私人从业者对有补偿肝硬化患者的建议的通信可以优化肝细胞癌筛查试验的规定。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号